Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ulrich T. Hacker

Prognostic Role of Body Composition Parameters in Gastric/Gastroesophageal Junction Cancer Patients From the EXPAND Trial

Journal of Cachexia, Sarcopenia and Muscle

English

Related publications

The Role of Pembrolizumab in the Treatment of PD-L1 Expressing Gastric and Gastroesophageal Junction Adenocarcinoma

Therapeutic Advances in Gastroenterology

Gastroenterology

2019

English

Correction To: Developing Real-World Comparators for Clinical Trials in Chemotherapy-Refractory Patients With Gastric Cancer or Gastroesophageal Junction Cancer

English

Exploratory Subgroup Analysis of Patients With Prior Trastuzumab Use in the ATTRACTION-2 Trial: A Randomized Phase III Clinical Trial Investigating the Efficacy and Safety of Nivolumab in Patients With Advanced Gastric/Gastroesophageal Junction Cancer

English

Pgi15 - Healthcare Resource Utilization (Hcru) in Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer Patients Receiving Second-Line Treatment

English

Prognostic Importance of the Inflammation-Based Glasgow Prognostic Score in Patients With Gastric Cancer

British Journal of Cancer

Cancer Research

Oncology

2012

English

Toxicity and Survival Outcomes of Adjuvant Chemoradiation for Gastric and Gastroesophageal Junction Cancer Patients Treated in Period 2006-2009: An Institutional Experience.

Neoplasma

Cancer Research

2014

English

The Gastric Outlet Herniated Through the Hiatus With the Normal Gastroesophageal Junction and Fundus

Turkish Journal of Gastroenterology

Gastroenterology

2017

English

Prognostic Factor of Gastric Carcinoma-Usefulness for Prognostic Factor and Improvement of Prognosis in Patients With Gastric Cancer.

Japanese Journal of Gastroenterological Surgery

Surgery

Gastroenterology

1993

English

Prognostic Significance of Baseline Positron Emission Tomography and Importance of Clinical Complete Response in Patients With Esophageal or Gastroesophageal Junction Cancer Treated With Definitive Chemoradiotherapy

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ulrich T. Hacker

Prognostic Role of Body Composition Parameters in Gastric/Gastroesophageal Junction Cancer Patients From the EXPAND Trial

Related publications

The Role of Pembrolizumab in the Treatment of PD-L1 Expressing Gastric and Gastroesophageal Junction Adenocarcinoma

Correction To: Developing Real-World Comparators for Clinical Trials in Chemotherapy-Refractory Patients With Gastric Cancer or Gastroesophageal Junction Cancer

Exploratory Subgroup Analysis of Patients With Prior Trastuzumab Use in the ATTRACTION-2 Trial: A Randomized Phase III Clinical Trial Investigating the Efficacy and Safety of Nivolumab in Patients With Advanced Gastric/Gastroesophageal Junction Cancer

Pgi15 - Healthcare Resource Utilization (Hcru) in Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer Patients Receiving Second-Line Treatment

Prognostic Importance of the Inflammation-Based Glasgow Prognostic Score in Patients With Gastric Cancer

Toxicity and Survival Outcomes of Adjuvant Chemoradiation for Gastric and Gastroesophageal Junction Cancer Patients Treated in Period 2006-2009: An Institutional Experience.

The Gastric Outlet Herniated Through the Hiatus With the Normal Gastroesophageal Junction and Fundus

Prognostic Factor of Gastric Carcinoma-Usefulness for Prognostic Factor and Improvement of Prognosis in Patients With Gastric Cancer.

Prognostic Significance of Baseline Positron Emission Tomography and Importance of Clinical Complete Response in Patients With Esophageal or Gastroesophageal Junction Cancer Treated With Definitive Chemoradiotherapy